• Medicare Part D reimbursement; Medicare Part D audit policy; Medicare anti-fraud, waste and abuse policy; Medicaid FFS drug reimbursement; Medicare innovative health care and delivery models; Post-acute care payment policy reform; Medicare Part D network access issues; Safe-harbor and anti-kickback policy
• Drug Enforcement Administration rule on disposal of controlled substances in long term care facilities; Reclassification of hydrocodone-containing prescription drugs from Schedule III to Schedule II drugs; Controlled substances policy; Biosimilars policy; Hazardous drug handling policy; FDA drug compounding policy

Duration: October 16, 2007 to September 30, 2015

General Issues: Medicare/Medicaid, Pharmacy, Health Issues, Insurance, Medical/Disease Research/Clinical Labs

Spending: about $3,365,047 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2007: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)